M Velia Antonini
@foamecmo.bsky.social
Perfusionist, E-AEC, ECMO & NRP specialist + POCUS
EuroELSO Steering C & Chair NRP Working Group
ELSOeducation taskforce
SoMe Director @TheELSO
SoMe Editor @asaiojournal
EuroELSO Steering C & Chair NRP Working Group
ELSOeducation taskforce
SoMe Director @TheELSO
SoMe Editor @asaiojournal
Pinned
M Velia Antonini
@foamecmo.bsky.social
· Nov 24
TA #NRP in cDCD heart donors using fully mobile closed #ECMO circuit, modified to provide
🩸🌡️effective NRP to support combined thoraco/abdominal organs recovery
🫀LV venting
🫀 fast conversion to central configuration as needed
⭕️ shunt for recirculation
🫧 air management
#FOAMcc
🔓 bit.ly/TANRPasaio
🩸🌡️effective NRP to support combined thoraco/abdominal organs recovery
🫀LV venting
🫀 fast conversion to central configuration as needed
⭕️ shunt for recirculation
🫧 air management
#FOAMcc
🔓 bit.ly/TANRPasaio
Frailty was not associated with short or long-term mortality among #ECMO patients: a reflection of eligibility patterns (selection practices + candidacy)? @anzics.bsky.social
Open access #FOAMcc #FOAMecmo
🔓 rdcu.be/eWWRx
Open access #FOAMcc #FOAMecmo
🔓 rdcu.be/eWWRx
Frailty & outcomes after #ECMO
🔍 cohort study across 116 ICUs from the Australia 🇦🇺 and New Zealand 🇳🇿
🔎 > 2K pts included (2018-2024); frailty present in 12.2% patients
🪦 adjusted 1y mortality 41.9% w/o frailty, 42.1% w frailty; results consistent across sensitivity/subgroup analyses
🔓 rdcu.be/eWWRx
🔍 cohort study across 116 ICUs from the Australia 🇦🇺 and New Zealand 🇳🇿
🔎 > 2K pts included (2018-2024); frailty present in 12.2% patients
🪦 adjusted 1y mortality 41.9% w/o frailty, 42.1% w frailty; results consistent across sensitivity/subgroup analyses
🔓 rdcu.be/eWWRx
December 30, 2025 at 1:43 PM
Frailty was not associated with short or long-term mortality among #ECMO patients: a reflection of eligibility patterns (selection practices + candidacy)? @anzics.bsky.social
Open access #FOAMcc #FOAMecmo
🔓 rdcu.be/eWWRx
Open access #FOAMcc #FOAMecmo
🔓 rdcu.be/eWWRx
🎥 Let's discuss #ECMO candidacy plenary session from day 2 of #ELSO2025, the 36th @theelso.bsky.social Annual Conference
🎥 #ECMO candidacy at #ELSO2025
🎤 Original #ECLS candidates
⚖️ Ethics & ECMO: is everyone a candidate?
🩺 Decisions at bedside Trisomy 18, cancer, #trauma, geriatrics
🍼 Mother & baby stories
To access register at
🔗 bit.ly/ELSO2025virtual
If you joined in Washington
🔗 elso2025.teneventsmedia.com
🎤 Original #ECLS candidates
⚖️ Ethics & ECMO: is everyone a candidate?
🩺 Decisions at bedside Trisomy 18, cancer, #trauma, geriatrics
🍼 Mother & baby stories
To access register at
🔗 bit.ly/ELSO2025virtual
If you joined in Washington
🔗 elso2025.teneventsmedia.com
December 29, 2025 at 1:16 PM
🎥 Let's discuss #ECMO candidacy plenary session from day 2 of #ELSO2025, the 36th @theelso.bsky.social Annual Conference
Antimicrobial pharmacokinetics and stewardship in critically Ill adult patients receiving #ECMO: challenges, evidence, and future directions
Open access #FOAMcc #FOAMecmo
🔓 bit.ly/45vjrbt
Open access #FOAMcc #FOAMecmo
🔓 bit.ly/45vjrbt
Antimicrobial in critically Ill adult patients receiving #ECMO: challenges, evidence, and future directions
💉 PK/PD concepts & considerations
🧫 antibacterials
🍄 antifungals
🦠 antivirals
🩺 management recommendations: dose optimization, challenges/recommendations, ABT stewardship
🔓 bit.ly/45vjrbt
💉 PK/PD concepts & considerations
🧫 antibacterials
🍄 antifungals
🦠 antivirals
🩺 management recommendations: dose optimization, challenges/recommendations, ABT stewardship
🔓 bit.ly/45vjrbt
December 28, 2025 at 6:33 PM
Antimicrobial pharmacokinetics and stewardship in critically Ill adult patients receiving #ECMO: challenges, evidence, and future directions
Open access #FOAMcc #FOAMecmo
🔓 bit.ly/45vjrbt
Open access #FOAMcc #FOAMecmo
🔓 bit.ly/45vjrbt
From VV of VP #ECMO in adults with severe respiratory failure complicated by refractory right ventricular dysfunction
@asaiojournal.bsky.social
🔗 bit.ly/4pimyuC
@asaiojournal.bsky.social
🔗 bit.ly/4pimyuC
Conversion VV of VP #ECMO?
🫘 facilitated #AKI resolution in 62.5% of patients with pre-conversion AKI, and was associated with liberation from CRRT in 40%
🩸 reduced pressor & ECMO flows requirements
💨 resulted in reduced SGF/FdO2 & FiO2
💉 facilitated sedation weaning
🔗 bit.ly/4pimyuC
🫘 facilitated #AKI resolution in 62.5% of patients with pre-conversion AKI, and was associated with liberation from CRRT in 40%
🩸 reduced pressor & ECMO flows requirements
💨 resulted in reduced SGF/FdO2 & FiO2
💉 facilitated sedation weaning
🔗 bit.ly/4pimyuC
December 27, 2025 at 6:05 PM
From VV of VP #ECMO in adults with severe respiratory failure complicated by refractory right ventricular dysfunction
@asaiojournal.bsky.social
🔗 bit.ly/4pimyuC
@asaiojournal.bsky.social
🔗 bit.ly/4pimyuC
Reposted by M Velia Antonini
In these times, we want to remember Dr. Bartlett. A tribute by @theelso.bsky.social on @asaiojournal.bsky.social
🔓 bit.ly/48TV8WT
Join us to celebrate his life & legacy
📆 Jan 25-26
📌 Ann Arbor
RSVP
🖋️ bit.ly/4q2O4wG
🖥️ A virtual event will be available: register for this option if you can't attend.
🔓 bit.ly/48TV8WT
Join us to celebrate his life & legacy
📆 Jan 25-26
📌 Ann Arbor
RSVP
🖋️ bit.ly/4q2O4wG
🖥️ A virtual event will be available: register for this option if you can't attend.
December 25, 2025 at 6:40 PM
In these times, we want to remember Dr. Bartlett. A tribute by @theelso.bsky.social on @asaiojournal.bsky.social
🔓 bit.ly/48TV8WT
Join us to celebrate his life & legacy
📆 Jan 25-26
📌 Ann Arbor
RSVP
🖋️ bit.ly/4q2O4wG
🖥️ A virtual event will be available: register for this option if you can't attend.
🔓 bit.ly/48TV8WT
Join us to celebrate his life & legacy
📆 Jan 25-26
📌 Ann Arbor
RSVP
🖋️ bit.ly/4q2O4wG
🖥️ A virtual event will be available: register for this option if you can't attend.
⏳ Beyond the edge: how far can we go in (safely) expanding warm ischemia time? Reflections on pushing the boundaries of WIT in DCD donors, leaving no heart behind. TA normothermic regional perfusion made feasible to overcome limits deemed as prohibitive until recently. 🪡🧵1/2
🔗 bit.ly/4pRZB2r
🔗 bit.ly/4pRZB2r
December 23, 2025 at 8:05 PM
⏳ Beyond the edge: how far can we go in (safely) expanding warm ischemia time? Reflections on pushing the boundaries of WIT in DCD donors, leaving no heart behind. TA normothermic regional perfusion made feasible to overcome limits deemed as prohibitive until recently. 🪡🧵1/2
🔗 bit.ly/4pRZB2r
🔗 bit.ly/4pRZB2r
Weaning from VV #ECMO: @esicm.bsky.social endorsed WEAN-ECMO survey
🚧 marked variability in current practices
🫁 standardization of criteria/protocols, including monitoring + SGOT duration, may improve comparability and support recommendations
#FOAMcc @intenscaremed.bsky.social
🔓 rdcu.be/eVTEY
🚧 marked variability in current practices
🫁 standardization of criteria/protocols, including monitoring + SGOT duration, may improve comparability and support recommendations
#FOAMcc @intenscaremed.bsky.social
🔓 rdcu.be/eVTEY
December 22, 2025 at 7:03 PM
Weaning from VV #ECMO: @esicm.bsky.social endorsed WEAN-ECMO survey
🚧 marked variability in current practices
🫁 standardization of criteria/protocols, including monitoring + SGOT duration, may improve comparability and support recommendations
#FOAMcc @intenscaremed.bsky.social
🔓 rdcu.be/eVTEY
🚧 marked variability in current practices
🫁 standardization of criteria/protocols, including monitoring + SGOT duration, may improve comparability and support recommendations
#FOAMcc @intenscaremed.bsky.social
🔓 rdcu.be/eVTEY
Reposted by M Velia Antonini
📖 Cannulas and Cannulations: let's read Blue Book Chapter 7
📋 #ECMO cannulation team roles
⚖️ cannula selection and routes of access
📋 ECLS primer workflow
📘 The Blue Book: the latest edition of the ELSO #ECMO Specialist Training Manual is NOW available in our online bookstore!
🛒 bit.ly/ELSObooks
📋 #ECMO cannulation team roles
⚖️ cannula selection and routes of access
📋 ECLS primer workflow
📘 The Blue Book: the latest edition of the ELSO #ECMO Specialist Training Manual is NOW available in our online bookstore!
🛒 bit.ly/ELSObooks
December 22, 2025 at 4:54 PM
📖 Cannulas and Cannulations: let's read Blue Book Chapter 7
📋 #ECMO cannulation team roles
⚖️ cannula selection and routes of access
📋 ECLS primer workflow
📘 The Blue Book: the latest edition of the ELSO #ECMO Specialist Training Manual is NOW available in our online bookstore!
🛒 bit.ly/ELSObooks
📋 #ECMO cannulation team roles
⚖️ cannula selection and routes of access
📋 ECLS primer workflow
📘 The Blue Book: the latest edition of the ELSO #ECMO Specialist Training Manual is NOW available in our online bookstore!
🛒 bit.ly/ELSObooks
Left ventricular recovery during VA #ECMO?
🫀 proposal of modified cardiac power output incorporating Pulse Pressure vs MAP, to avoid poor or absent pulsatility and/or ineffective unloading biasing its interpretation in reflecting the efficacy of organ perfusion
#FOAMcc #FOAMecmo
🔓 rdcu.be/eVDKb
🫀 proposal of modified cardiac power output incorporating Pulse Pressure vs MAP, to avoid poor or absent pulsatility and/or ineffective unloading biasing its interpretation in reflecting the efficacy of organ perfusion
#FOAMcc #FOAMecmo
🔓 rdcu.be/eVDKb
December 20, 2025 at 5:52 PM
Left ventricular recovery during VA #ECMO?
🫀 proposal of modified cardiac power output incorporating Pulse Pressure vs MAP, to avoid poor or absent pulsatility and/or ineffective unloading biasing its interpretation in reflecting the efficacy of organ perfusion
#FOAMcc #FOAMecmo
🔓 rdcu.be/eVDKb
🫀 proposal of modified cardiac power output incorporating Pulse Pressure vs MAP, to avoid poor or absent pulsatility and/or ineffective unloading biasing its interpretation in reflecting the efficacy of organ perfusion
#FOAMcc #FOAMecmo
🔓 rdcu.be/eVDKb
🎥 More machine now than man: mechanically assisted resuscitations session moderated by Max Hockstein & Jan Belohlavek, from day 1 of #ELSO2025, the 36th ELSO Annual Conference
🎥 Mechanically assisted resuscitation at #ELSO2025
🩺 CA physiology & therapeutic targets
⚙️mechanical CPR devices and feedback
🩸rethinking #ECMO flow
🫀ECLS for IHCA & 🚑 OHCA
To access register as virtual attendee
🔗 bit.ly/ELSO2025virt...
If you joined in Washington visit
🔗 elso2025.teneventsmedia.com
🩺 CA physiology & therapeutic targets
⚙️mechanical CPR devices and feedback
🩸rethinking #ECMO flow
🫀ECLS for IHCA & 🚑 OHCA
To access register as virtual attendee
🔗 bit.ly/ELSO2025virt...
If you joined in Washington visit
🔗 elso2025.teneventsmedia.com
December 19, 2025 at 5:21 PM
🎥 More machine now than man: mechanically assisted resuscitations session moderated by Max Hockstein & Jan Belohlavek, from day 1 of #ELSO2025, the 36th ELSO Annual Conference
#ECLS following aortic surgery?
🩸 strategies as standardized anticoagulation protocols,
early monitoring, meticulous hemostasis (& delayed chest closure if appropriate) essential
🧠 individualized cerebral protection, careful CPP management, preop imaging should be considered to reduce stroke risk
🩸 strategies as standardized anticoagulation protocols,
early monitoring, meticulous hemostasis (& delayed chest closure if appropriate) essential
🧠 individualized cerebral protection, careful CPP management, preop imaging should be considered to reduce stroke risk
#ECLS following aortic surgery
🪦 mortality (8%) higher vs other groups, but not enough to consider aortic surgery as contraindication. Emergency status did not affect mortality
Better complication prevention pivotal, particularly bleedings & neuro events.
@asaiojournal.bsky.social
🔗 bit.ly/49jJAMM
🪦 mortality (8%) higher vs other groups, but not enough to consider aortic surgery as contraindication. Emergency status did not affect mortality
Better complication prevention pivotal, particularly bleedings & neuro events.
@asaiojournal.bsky.social
🔗 bit.ly/49jJAMM
December 18, 2025 at 3:07 PM
#ECLS following aortic surgery?
🩸 strategies as standardized anticoagulation protocols,
early monitoring, meticulous hemostasis (& delayed chest closure if appropriate) essential
🧠 individualized cerebral protection, careful CPP management, preop imaging should be considered to reduce stroke risk
🩸 strategies as standardized anticoagulation protocols,
early monitoring, meticulous hemostasis (& delayed chest closure if appropriate) essential
🧠 individualized cerebral protection, careful CPP management, preop imaging should be considered to reduce stroke risk
🚑 ECPR in severe trauma: how can pt dying of exsanguination, resp failure, tamponade survive prolonged no flow when chest compressions fail to circulate blood? This has parallels to paradigm shift (15y ago): brain/heart may recover after 60' CPR restoring perfusion w #ECMO
@resuscitation.bsky.social
@resuscitation.bsky.social
🚑 #ECPR in severe trauma patient in CA: physiology, data, confounders. When should we try?.
Editorial
🔗 bit.ly/4jcWfV9
🚑 Refer to analysis of the ELSO registry on use of #extracorporeal cardiopulmonary resuscitation in trauma patients.
🔗 bit.ly/4rYCN2B
Editorial
🔗 bit.ly/4jcWfV9
🚑 Refer to analysis of the ELSO registry on use of #extracorporeal cardiopulmonary resuscitation in trauma patients.
🔗 bit.ly/4rYCN2B
December 17, 2025 at 6:12 PM
🚑 ECPR in severe trauma: how can pt dying of exsanguination, resp failure, tamponade survive prolonged no flow when chest compressions fail to circulate blood? This has parallels to paradigm shift (15y ago): brain/heart may recover after 60' CPR restoring perfusion w #ECMO
@resuscitation.bsky.social
@resuscitation.bsky.social
Reposted by M Velia Antonini
⏰ Tomorrow at 18:00:final session
The second & last Best of ESOT Congress webinar dives into:
🧬 Transplant immunology
💡 Innovation in immunosuppression
🩺 Long-term complications
Led by Olivier Thaunat & Colin Wilson
👉 Register now & join live
The second & last Best of ESOT Congress webinar dives into:
🧬 Transplant immunology
💡 Innovation in immunosuppression
🩺 Long-term complications
Led by Olivier Thaunat & Colin Wilson
👉 Register now & join live
Best of ESOT Congress 2025: Vol 2
go.esot.org
December 17, 2025 at 6:05 PM
⏰ Tomorrow at 18:00:final session
The second & last Best of ESOT Congress webinar dives into:
🧬 Transplant immunology
💡 Innovation in immunosuppression
🩺 Long-term complications
Led by Olivier Thaunat & Colin Wilson
👉 Register now & join live
The second & last Best of ESOT Congress webinar dives into:
🧬 Transplant immunology
💡 Innovation in immunosuppression
🩺 Long-term complications
Led by Olivier Thaunat & Colin Wilson
👉 Register now & join live
Reposted by M Velia Antonini
🎵 Site survey for the @theelso.bsky.social Office & ELSO congress chair: work in progress for #ELSO2026 🎶 the 37th Annual Conference of the ELSO - Extracorporeal Life Support Organization
Save the date ‼️
📌 Nashville, Tennessee
📆 September 27 - October 1, 2026
Save the date ‼️
📌 Nashville, Tennessee
📆 September 27 - October 1, 2026
December 16, 2025 at 8:34 PM
🎵 Site survey for the @theelso.bsky.social Office & ELSO congress chair: work in progress for #ELSO2026 🎶 the 37th Annual Conference of the ELSO - Extracorporeal Life Support Organization
Save the date ‼️
📌 Nashville, Tennessee
📆 September 27 - October 1, 2026
Save the date ‼️
📌 Nashville, Tennessee
📆 September 27 - October 1, 2026
Any role for nitric oxide in the sweep gas flow to the membrane lung during #ECMO?? YES!
Join the 🐾 SNOOPI inaugural webinar to gain insight into
🧪 biology of NO
🩺 clinical experience & how to use
🔍 latest (& future) research
open access🔓
📆 January 12, 2026
⏰ 8-10:00 am EST
Register 🔗 bit.ly/44uFizx
Join the 🐾 SNOOPI inaugural webinar to gain insight into
🧪 biology of NO
🩺 clinical experience & how to use
🔍 latest (& future) research
open access🔓
📆 January 12, 2026
⏰ 8-10:00 am EST
Register 🔗 bit.ly/44uFizx
December 16, 2025 at 5:43 PM
Any role for nitric oxide in the sweep gas flow to the membrane lung during #ECMO?? YES!
Join the 🐾 SNOOPI inaugural webinar to gain insight into
🧪 biology of NO
🩺 clinical experience & how to use
🔍 latest (& future) research
open access🔓
📆 January 12, 2026
⏰ 8-10:00 am EST
Register 🔗 bit.ly/44uFizx
Join the 🐾 SNOOPI inaugural webinar to gain insight into
🧪 biology of NO
🩺 clinical experience & how to use
🔍 latest (& future) research
open access🔓
📆 January 12, 2026
⏰ 8-10:00 am EST
Register 🔗 bit.ly/44uFizx
Had the honour to give the talk
🚑 #ECPR to organ donation
during the @theelso.bsky.social & @ishlt.bsky.social #ELSO2025 session: maximizing the donor pool, #ECMO driven advances in cardiothoracic #transplantation
Access to replay through the virtual platform registering at
🔗 bit.ly/ELSO2025virtual
🚑 #ECPR to organ donation
during the @theelso.bsky.social & @ishlt.bsky.social #ELSO2025 session: maximizing the donor pool, #ECMO driven advances in cardiothoracic #transplantation
Access to replay through the virtual platform registering at
🔗 bit.ly/ELSO2025virtual
December 14, 2025 at 6:55 PM
Had the honour to give the talk
🚑 #ECPR to organ donation
during the @theelso.bsky.social & @ishlt.bsky.social #ELSO2025 session: maximizing the donor pool, #ECMO driven advances in cardiothoracic #transplantation
Access to replay through the virtual platform registering at
🔗 bit.ly/ELSO2025virtual
🚑 #ECPR to organ donation
during the @theelso.bsky.social & @ishlt.bsky.social #ELSO2025 session: maximizing the donor pool, #ECMO driven advances in cardiothoracic #transplantation
Access to replay through the virtual platform registering at
🔗 bit.ly/ELSO2025virtual
Reposted by M Velia Antonini
📖 Nursing #ECLS Patients: let's open the Blue Book! Chapter 5 outlines roles & responsibilities of nurses taking care of patients on #ECMO
📋 nursing scope
🩺 physical assessment
🦼 in-hospital transport
🧫 cannula management + infection prevention
🤝 patient/family involvement
🛒 bit.ly/ELSObooks
📋 nursing scope
🩺 physical assessment
🦼 in-hospital transport
🧫 cannula management + infection prevention
🤝 patient/family involvement
🛒 bit.ly/ELSObooks
December 8, 2025 at 4:10 PM
📖 Nursing #ECLS Patients: let's open the Blue Book! Chapter 5 outlines roles & responsibilities of nurses taking care of patients on #ECMO
📋 nursing scope
🩺 physical assessment
🦼 in-hospital transport
🧫 cannula management + infection prevention
🤝 patient/family involvement
🛒 bit.ly/ELSObooks
📋 nursing scope
🩺 physical assessment
🦼 in-hospital transport
🧫 cannula management + infection prevention
🤝 patient/family involvement
🛒 bit.ly/ELSObooks
4️⃣ strategies for #DCD lung #transplantation: recording of @ishlt.bsky.social webinar exploring approaches to donation after circulatory determination of death and LTx
🫁 EVLP - OCS
🫁 EVLP - XVIVO System: US/EU Perspectives
🔪 direct procurement
🩸 normothermic regional perfusion #NRP
🎥 bit.ly/48nKCqH
🫁 EVLP - OCS
🫁 EVLP - XVIVO System: US/EU Perspectives
🔪 direct procurement
🩸 normothermic regional perfusion #NRP
🎥 bit.ly/48nKCqH
December 7, 2025 at 10:10 AM
4️⃣ strategies for #DCD lung #transplantation: recording of @ishlt.bsky.social webinar exploring approaches to donation after circulatory determination of death and LTx
🫁 EVLP - OCS
🫁 EVLP - XVIVO System: US/EU Perspectives
🔪 direct procurement
🩸 normothermic regional perfusion #NRP
🎥 bit.ly/48nKCqH
🫁 EVLP - OCS
🫁 EVLP - XVIVO System: US/EU Perspectives
🔪 direct procurement
🩸 normothermic regional perfusion #NRP
🎥 bit.ly/48nKCqH
VV #ECMO in immunocompromised patients with acute respiratory failure: careful, tailored clinical decision regarding ECMO candidacy pivotal!
@asaiojournal.bsky.social
🔗 bit.ly/4oPxFuU
@asaiojournal.bsky.social
🔗 bit.ly/4oPxFuU
VV #ECMO in immunocompromised patients with respiratory failure
🔍 systematic review/meta-analysis (13 studies)
🪦 mortality 63%, significantly higher vs immunocompetent pts
🪦 subgroup analysis highlighted only pts with hematologic malignancy exhibited significantly higher mortality
🔗 bit.ly/4oPxFuU
🔍 systematic review/meta-analysis (13 studies)
🪦 mortality 63%, significantly higher vs immunocompetent pts
🪦 subgroup analysis highlighted only pts with hematologic malignancy exhibited significantly higher mortality
🔗 bit.ly/4oPxFuU
December 6, 2025 at 6:08 PM
VV #ECMO in immunocompromised patients with acute respiratory failure: careful, tailored clinical decision regarding ECMO candidacy pivotal!
@asaiojournal.bsky.social
🔗 bit.ly/4oPxFuU
@asaiojournal.bsky.social
🔗 bit.ly/4oPxFuU
ECPR in neuroleptic malignant syndrome? #ECMO may be considered as bridge to recovery while correcting extreme hyperkalemia/normalizing temperature. Timely initiation (before CA?) pivotal to improve outcome. If negative neuro-evolution opportunity of organ donation should be offered
🖇️ bit.ly/3Y7uqns
🖇️ bit.ly/3Y7uqns
December 5, 2025 at 7:00 PM
ECPR in neuroleptic malignant syndrome? #ECMO may be considered as bridge to recovery while correcting extreme hyperkalemia/normalizing temperature. Timely initiation (before CA?) pivotal to improve outcome. If negative neuro-evolution opportunity of organ donation should be offered
🖇️ bit.ly/3Y7uqns
🖇️ bit.ly/3Y7uqns
Weaning from VV #ECMO for acute respiratory failure, current understanding/emerging data
📋 protocolized weaning in critical care & emerging evidence
🫁 approach to #ECLS weaning
🫁 physiologic predictors of successful weaning
🚧 challenges
🩺 approach to difficult-to-wean pt
#ICUrehab
🔗 bit.ly/4iImx1u
📋 protocolized weaning in critical care & emerging evidence
🫁 approach to #ECLS weaning
🫁 physiologic predictors of successful weaning
🚧 challenges
🩺 approach to difficult-to-wean pt
#ICUrehab
🔗 bit.ly/4iImx1u
December 4, 2025 at 12:38 PM
Weaning from VV #ECMO for acute respiratory failure, current understanding/emerging data
📋 protocolized weaning in critical care & emerging evidence
🫁 approach to #ECLS weaning
🫁 physiologic predictors of successful weaning
🚧 challenges
🩺 approach to difficult-to-wean pt
#ICUrehab
🔗 bit.ly/4iImx1u
📋 protocolized weaning in critical care & emerging evidence
🫁 approach to #ECLS weaning
🫁 physiologic predictors of successful weaning
🚧 challenges
🩺 approach to difficult-to-wean pt
#ICUrehab
🔗 bit.ly/4iImx1u
LEVOECMO RCT
💉 levosimendan, 0.15 μg/kg/min, to be increased to 0.20 μg/kg/min after 2 h or placebo
⚖️ no significantly shorten time to successful weaning of #ECMO at day 30: routine use not supported
⚖️ run duration, #ICU LoS, 60-day mortality did not differ significantly
@jama.com
🖇️ bit.ly/4iAwGwT
💉 levosimendan, 0.15 μg/kg/min, to be increased to 0.20 μg/kg/min after 2 h or placebo
⚖️ no significantly shorten time to successful weaning of #ECMO at day 30: routine use not supported
⚖️ run duration, #ICU LoS, 60-day mortality did not differ significantly
@jama.com
🖇️ bit.ly/4iAwGwT
LEVOECMO RCT: early administration of levosimendan to facilitate weaning from VA #ECMO in severe but potentially reversible cardiogenic shock
🔍 205 adults/11 ICUs in 🇫🇷
⚖️ early levosimendan administration did not significantly shorten the time to successful weaning of #ECLS at day 30
🔗 bit.ly/4iAwGwT
🔍 205 adults/11 ICUs in 🇫🇷
⚖️ early levosimendan administration did not significantly shorten the time to successful weaning of #ECLS at day 30
🔗 bit.ly/4iAwGwT
December 2, 2025 at 6:29 PM
LEVOECMO RCT
💉 levosimendan, 0.15 μg/kg/min, to be increased to 0.20 μg/kg/min after 2 h or placebo
⚖️ no significantly shorten time to successful weaning of #ECMO at day 30: routine use not supported
⚖️ run duration, #ICU LoS, 60-day mortality did not differ significantly
@jama.com
🖇️ bit.ly/4iAwGwT
💉 levosimendan, 0.15 μg/kg/min, to be increased to 0.20 μg/kg/min after 2 h or placebo
⚖️ no significantly shorten time to successful weaning of #ECMO at day 30: routine use not supported
⚖️ run duration, #ICU LoS, 60-day mortality did not differ significantly
@jama.com
🖇️ bit.ly/4iAwGwT
📖 Management of anticoagulants and blood products in children and adults on #ECMO
🩸 anticoagulants: UFH & DTI
🩸 hemostatic monitoring: antiXa, AT, aPTT, ECT, plasma diluted thrombin time, coagulation factor monitoring, ACT, VET
🩸 blood products: anticoagulant reversal & adjunctive therapies
🩸 anticoagulants: UFH & DTI
🩸 hemostatic monitoring: antiXa, AT, aPTT, ECT, plasma diluted thrombin time, coagulation factor monitoring, ACT, VET
🩸 blood products: anticoagulant reversal & adjunctive therapies
📖 Management of anticoagulants and blood products in children and adults on #ECMO: let's open Blue Book! Chapter 4 outlines the principles of anticoagulation administration/monitoring in #ECLS across all age groups & transfusion triggers/blood product administration
📘 Available at
🛒 bit.ly/ELSObooks
📘 Available at
🛒 bit.ly/ELSObooks
December 1, 2025 at 5:39 PM
📖 Management of anticoagulants and blood products in children and adults on #ECMO
🩸 anticoagulants: UFH & DTI
🩸 hemostatic monitoring: antiXa, AT, aPTT, ECT, plasma diluted thrombin time, coagulation factor monitoring, ACT, VET
🩸 blood products: anticoagulant reversal & adjunctive therapies
🩸 anticoagulants: UFH & DTI
🩸 hemostatic monitoring: antiXa, AT, aPTT, ECT, plasma diluted thrombin time, coagulation factor monitoring, ACT, VET
🩸 blood products: anticoagulant reversal & adjunctive therapies
Percutaneous multisite VV cannulation in neonates and infants could be feasible (if experienced teams), providing adequate support with smaller than recommended cannulas, and lower risk of thrombosis. Editorial
🔗 bit.ly/3KcvhQx
Refers to
🔓 bit.ly/4nNZxz0
🔗 bit.ly/3KcvhQx
Refers to
🔓 bit.ly/4nNZxz0
November 29, 2025 at 2:44 PM
🎥 Adult VA #ECMO: breakout session from day 1 of #ELSO2025, the 36th @theelso.bsky.social Annual Conference
🎥 Adult VA #ECMO, day 1 #ELSO2025
🫀 what device & when for post cardiotomy shock
🫀 upper body access via axillary or subclavian artery
🫀 how to wean multiple devices
🫀 complications with vascular grafts
🎤 debate Impella 5.5 should be used in all high-risk cardiac surgery pts
🔗 bit.ly/ELSO2025virtual
🫀 what device & when for post cardiotomy shock
🫀 upper body access via axillary or subclavian artery
🫀 how to wean multiple devices
🫀 complications with vascular grafts
🎤 debate Impella 5.5 should be used in all high-risk cardiac surgery pts
🔗 bit.ly/ELSO2025virtual
November 28, 2025 at 5:21 PM
🎥 Adult VA #ECMO: breakout session from day 1 of #ELSO2025, the 36th @theelso.bsky.social Annual Conference